| Lastest Insider Transactions Of KalVista Pharmaceuticals, Inc. ( KALV ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| KALV | KalVista Pharmaceuticals, Inc. | Cha Albert | Directior | 2019-07-26 | Buy | 56,367 | 16.99 | 957,737 | 2019-07-30 19:37:00 |
| KALV | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | 2019-07-22 | Sell | 7,355 | 18.35 | 134,930 | 2019-07-24 17:53:52 |
| KALV | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | 2019-07-22 | Option Exercise | 7,355 | 0.00 | 32 | 2019-07-24 17:53:52 |
| KALV | KalVista Pharmaceuticals, Inc. | Feener Edward P. | Chief Scientific Officer | 2019-07-22 | Sell | 3,300 | 18.62 | 61,443 | 2019-07-24 17:52:44 |
| KALV | KalVista Pharmaceuticals, Inc. | Cha Albert | Directior | 2019-07-17 | Buy | 61,280 | 17.79 | 1,090,296 | 2019-07-19 18:38:57 |
| KALV | KalVista Pharmaceuticals, Inc. | Crockett Thomas Andrew | CEO | 2019-07-15 | Sell | 10,000 | 17.04 | 170,407 | 2019-07-17 18:52:49 |
| KALV | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | 2019-04-22 | Sell | 7,355 | 26.04 | 191,530 | 2019-04-23 17:33:08 |
| KALV | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | 2019-04-22 | Option Exercise | 7,355 | 0.00 | 32 | 2019-04-23 17:33:08 |
| KALV | KalVista Pharmaceuticals, Inc. | Crockett Thomas Andrew | CEO | 2019-04-15 | Sell | 10,000 | 24.80 | 247,958 | 2019-04-23 17:30:51 |
| KALV | KalVista Pharmaceuticals, Inc. | Palleiko Benjamin L | CBO, CFO and Secretary | 2019-04-18 | Sell | 3,073 | 25.70 | 78,976 | 2019-04-22 17:58:34 |
| KALV | KalVista Pharmaceuticals, Inc. | Palleiko Benjamin L | CBO, CFO and Secretary | 2019-04-18 | Option Exercise | 3,073 | 7.81 | 24,012 | 2019-04-22 17:58:34 |
| KALV | KalVista Pharmaceuticals, Inc. | Feener Edward P. | Chief Scientific Officer | 2019-04-17 | Sell | 4,000 | 24.92 | 99,666 | 2019-04-18 18:30:04 |
| KALV | KalVista Pharmaceuticals, Inc. | SVLSF IV, LLC | 10% Owner | 2019-04-08 | Sell | 50,000 | 29.20 | 1,460,145 | 2019-04-10 19:21:59 |
| KALV | KalVista Pharmaceuticals, Inc. | Maetzel Andreas | Senior Vice President Medical | 2019-04-05 | Sell | 5,000 | 30.00 | 150,011 | 2019-04-09 17:33:01 |
| KALV | KalVista Pharmaceuticals, Inc. | Maetzel Andreas | Senior Vice President Medical | 2019-04-05 | Option Exercise | 5,000 | 7.91 | 39,550 | 2019-04-09 17:33:01 |
| KALV | KalVista Pharmaceuticals, Inc. | SVLSF IV, LLC | 10% Owner | 2019-03-29 | Sell | 97,074 | 28.03 | 2,720,897 | 2019-04-02 18:57:58 |
| KALV | KalVista Pharmaceuticals, Inc. | SVLSF IV, LLC | 10% Owner | 2019-03-26 | Sell | 124,675 | 28.84 | 3,596,032 | 2019-03-28 17:29:52 |
| KALV | KalVista Pharmaceuticals, Inc. | SVLSF IV, LLC | 10% Owner | 2019-03-18 | Sell | 262,470 | 26.70 | 7,007,949 | 2019-03-20 16:13:54 |
| KALV | KalVista Pharmaceuticals, Inc. | Venrock Healthcare Capital Partners II, L.P. | 10% Owner | 2019-03-18 | Sell | 500,000 | 28.75 | 14,375,000 | 2019-03-20 16:08:57 |
| KALV | KalVista Pharmaceuticals, Inc. | Crockett Thomas Andrew | CEO | 2019-03-14 | Sell | 3,000 | 30.16 | 90,484 | 2019-03-15 20:03:23 |
| KALV | KalVista Pharmaceuticals, Inc. | SVLSF IV, LLC | 10% Owner | 2019-03-04 | Sell | 75,710 | 22.96 | 1,738,476 | 2019-03-06 09:05:30 |
| KALV | KalVista Pharmaceuticals, Inc. | SVLSF IV, LLC | 10% Owner | 2019-02-19 | Sell | 214,198 | 20.55 | 4,401,354 | 2019-02-21 14:35:52 |
| KALV | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | 2019-01-25 | Sell | 5,453 | 17.06 | 93,015 | 2019-01-29 18:53:45 |
| KALV | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | 2019-01-25 | Option Exercise | 5,453 | 0.00 | 23 | 2019-01-29 18:53:45 |
| KALV | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | 2019-01-22 | Sell | 1,902 | 17.01 | 32,344 | 2019-01-24 19:48:04 |
| KALV | KalVista Pharmaceuticals, Inc. | Yea Christopher | Chief Development Officer | 2019-01-22 | Option Exercise | 1,902 | 0.00 | 8 | 2019-01-24 19:48:04 |
| KALV | KalVista Pharmaceuticals, Inc. | Feener Edward P. | Chief Scientific Officer | 2019-01-16 | Sell | 4,000 | 19.55 | 78,210 | 2019-01-18 17:42:14 |
| KALV | KalVista Pharmaceuticals, Inc. | Crockett Thomas Andrew | CEO | 2019-01-14 | Sell | 10,000 | 19.33 | 193,328 | 2019-01-16 18:25:55 |
| KALV | KalVista Pharmaceuticals, Inc. | SVLSF IV, LLC | 10% Owner | 2019-01-03 | Sell | 4,299 | 20.25 | 87,073 | 2019-01-07 17:12:06 |
| KALV | KalVista Pharmaceuticals, Inc. | SVLSF IV, LLC | 10% Owner | 2018-12-28 | Sell | 29,352 | 20.01 | 587,243 | 2019-01-02 19:10:56 |
| KALV | KalVista Pharmaceuticals, Inc. | SVLSF IV, LLC | 10% Owner | 2018-12-19 | Sell | 2,136 | 20.02 | 42,758 | 2018-12-21 16:19:53 |
| KALV | KalVista Pharmaceuticals, Inc. | ORONSKY ARNOLD L | Directior | 2018-09-10 | Buy | 58,824 | 17.00 | 1,000,008 | 2018-09-12 19:16:36 |
| KALV | KalVista Pharmaceuticals, Inc. | Cha Albert | Directior | 2018-09-10 | Buy | 1,058,824 | 17.00 | 18,000,008 | 2018-09-12 19:11:55 |
